AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,155 | -12.1% | 85,186 | +176.6% | 0.00% | -100.0% |
Q4 2021 | $69,601 | -62.1% | 30,797 | -51.7% | 0.00% | -50.0% |
Q3 2021 | $183,531 | +49.1% | 63,726 | +96.2% | 0.00% | +100.0% |
Q2 2021 | $123,103 | -40.3% | 32,481 | -46.7% | 0.00% | -50.0% |
Q1 2021 | $206,133 | +129.4% | 60,896 | +89.7% | 0.00% | +100.0% |
Q4 2020 | $89,869 | +26.5% | 32,096 | +13.4% | 0.00% | 0.0% |
Q3 2020 | $71,025 | -91.0% | 28,297 | -51.4% | 0.00% | -88.9% |
Q2 2020 | $790,044 | +99.6% | 58,177 | +11.4% | 0.01% | +50.0% |
Q1 2020 | $395,873 | +50.5% | 52,226 | +25.5% | 0.01% | +100.0% |
Q4 2019 | $263,007 | +17.0% | 41,615 | -27.4% | 0.00% | 0.0% |
Q3 2019 | $224,718 | -19.0% | 57,326 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $277,456 | -16.6% | 57,326 | +41.2% | 0.00% | -25.0% |
Q1 2019 | $332,580 | +48.1% | 40,608 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $224,562 | +18.7% | 40,608 | +89.5% | 0.00% | +50.0% |
Q3 2018 | $189,218 | -11.6% | 21,429 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $214,000 | +4.9% | 21,429 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $204,000 | -36.1% | 21,429 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $319,000 | – | 21,429 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |